MBS2097863 | Mini Samples Human Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ELISA Kit

(No reviews yet) Write a Review
SKU:
MBS2097863
Availability:
Usually Shipped in 5 Working Days
NULL456.00 - NULL6,291.00
Frequently bought together:

Description

Mini Samples Human Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) ELISA Kit | MBS2097863 | Mybiosource

Product Short Name: [Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)]

Product Name Synonyme: [P16; ARF; CDK4I; CMM2; INK4; INK4a; MLM; MTS1; TP16; P14; P14ARF; P16INK4a; P19; Melanoma P16; Cyclin-dependent kinase 4 inhibitor A; Multiple tumor suppressor 1]

Other Names: [cyclin-dependent kinase inhibitor 2A isoform p16INK4a; Cyclin-dependent kinase inhibitor 2A; cyclin-dependent kinase inhibitor 2A; cyclin dependent kinase inhibitor 2A; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; p16-INK4a; p16-INK4; p16INK4A]

Product Gene Name: [CDKN2A]

Product Gene Name Synonyme: N/A

Other Gene Names: [CDKN2A; CDKN2A; ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P16INK4; P16INK4A; P16-INK4A; CDK4I; MTS-1; p16-INK4; p16INK4A]

Clonality: N/A

Isotype: N/A

Clone: N/A

Host: N/A

Reactivity: Human

Specificity: This assay has high sensitivity and excellent specificity for detection of Mini Samples Cyclin Dependent Kinase Inhibitor 2A (CDKN2A).
No significant cross-reactivity or interference between Mini Samples Cyclin Dependent Kinase Inhibitor 2A (CDKN2A) and analogues was observed.

Purity: N/A

Form: N/A

Concentration: N/A

Storage Stability: The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Tested Application: N/A

View AllClose